An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Inogen, Inc (NASDAQ: INGN) announced its first quarter 2022 financial results will be released after market close on May 5, 2022. The company will host a conference call at 2:00pm PT / 5:00pm ET to discuss these results. Interested parties can listen by calling (877) 841-3961 for domestic or (201) 689-8589 for international access. A replay will be available from 4:00pm PT on the same day until 4:00pm PT on May 19, 2022. Access to the webcast will also be provided via Inogen's investor relations website.
Positive
None.
Negative
None.
GOLETA, Calif.--(BUSINESS WIRE)--
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2022 financial results after market close on Thursday, May 5, 2022. The Company will host a corresponding conference call beginning at 2:00pm PT/5:00pm ET.
Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 689-8589 for international callers. Please reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at: http://investor.inogen.com/.
A replay of the call will be available beginning, May 5, 2022 at 4:00pm PT/ 7:00pm ET through 4:00pm PT/ 7:00pm ET on May 19, 2022. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Conference ID: 13727825. The webcast will also be available on Inogen's website for one year following the completion of the call.
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.
About Inogen
We are a medical technology company offering innovative respiratory products for use in the homecare setting. We primarily develop, manufacture and market innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.